WuXi Diagnostics (WXDX) is establishing a next-generation integrated diagnostic enabling platform with headquarters and a CAP-accredited Independent Clinical Laboratory in Shanghai, a production facility of In Vitro Diagnostic reagent kits and instruments in Suzhou, and an R&D center at Mayo Clinic headquarters in Rochester, U.S. It is providing multidisciplinary technology solutions to improve health care practice and advance patient care.
Its core product, Enabling Solution Package (ESP), is a disease-focused total solution with advanced testing panels, medical paradigm and algorithms for disease diagnosis, and insightful medical content based on real-world clinical evidence. ESPs cover four phases of disease management: screening & early diagnosis, precision diagnosis, clinical decision support, and prognosis management.
WXDX dual enabling platforms for specialized testing service and medical innovation are advancing China’ s precision diagnosis and building a new ecosystem for next generation diagnostics.
Company Details
- Employees
- 42
- Founded
- 2018
- Address
- Lane 31 Yiwei Road, Waigaoqiao, Shanghai,shanghai 200131,china
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- wuxidiagnostics.com
- HQ
- Shanghai, Shanghai
Wuxi Diagnostics Questions
Wuxi Diagnostics's website is wuxidiagnostics.com
Wuxi Diagnostics's LinkedIn profile is https://cn.linkedin.com/company/wxdx
Wuxi Diagnostics has
42 employees.
View email and phone details for 42
employees at Wuxi Diagnostics.
Wuxi Diagnostics's industry is
Hospitals and Health Care
Wuxi Diagnostics's top competitors are
Shenzhen Root Technology Co.,ltd,
Wuxi Biologics,
Wuxi Apptec,
Hologic (Formerly Gen-Probe),
Life Technologies,
Shanghai Happy Plex Industry And Trade Co., Ltd,
Xiamen Senyang Co.,ltd.,
Invvo Group,
Zekes3d,
Shanghai Jiahui International Hospital.
Wuxi Diagnostics's categories are Hospitals and Health Care
Wuxi Diagnostics's founding year is 2018
